0

Global Insulinoma Treatment Market 2019-2023

  • Published: Dec 2018
  • Pages: 122
  • SKU: IRTNTR30576
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global insulinoma treatment market size will grow by over USD 468 million during 2019-2023. This report provides a detailed analysis of the market based on type (surgery, drugs, and other treatments) and geography (the Americas, APAC, and EMEA). The report analyzes the market’s competitive landscape and offers information on several insulinoma treatment companies including Ipsen Pharma, Johnson & Johnson, Novartis, Pfizer, and Teva Pharmaceutical Industries.

Some of the key findings from our insulinoma treatment market forecast report are summarized below

insulinoma treatment

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

        

Global insulinoma treatment industry overview

Insulinoma is a rare type of pancreatic neuroendocrine tumor that produces excess insulin and thereby reduces blood sugar levels. Although most of these tumors are benign, insulinoma can cause severe hypoglycemia which can be fatal if left untreated. Surgical removal of the tumor is the best treatment for insulinoma. Recent advancements in technology have enabled the use of laparoscopic surgery for insulinoma treatment. Since surgery is the first line of treatment for insulinoma, technological advancements will play a vital role in the development of the insulinoma treatment market. The global insulinoma treatment market is expected to grow at a CAGR of over 3% during the forecast period.

Top insulinoma treatment companies covered in this market research report

The global insulinoma treatment market is moderately concentrated, and as the market is in a growth phase, the competition is intense. To help clients improve their revenue shares in the market, this research report provides an analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this insulinoma treatment market analysis report suggests strategies companies can follow and recommends key areas they should focus on, to make the most of upcoming growth opportunities.

The report offers a detailed analysis of several leading companies, including:

  • Ipsen Pharma
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Teva Pharmaceutical Industries

Insulinoma treatment market segmentation based on the type

  • Surgery
  • Drugs
  • Other treatments

The surgery segment will account for the highest share in the insulinoma treatment market because of its increasing popularity since it is a curative method and most preferred choice of treatment. Additionally, the report also provides an accurate prediction of the contribution of the various segments to the growth of the insulinoma treatment market size.

Insulinoma treatment market segmentation based on geographic region

  • Americas
  • APAC
  • EMEA

A complete study of the growth opportunities in the insulinoma treatment market indicates, the Americas will account for the highest growth of the insulinoma treatment market throughout the forecast period. Improved diagnostic methods and technological advancements in surgery are some of the factors responsible for insulinoma treatment market growth in this region.

Key highlights of the global insulinoma treatment market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the insulinoma treatment market during the next five years
  • Precise estimation of the global insulinoma treatment market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the insulinoma treatment industry across the Americas, APAC, and EMEA
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on factors that will challenge the growth of insulinoma treatment companies

 

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Surgery - Market size and forecast 2018-2023
  • Drugs - Market size and forecast 2018-2023
  • Other treatments - Market size and forecast 2018-2023
  • Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Ipsen Pharma
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Teva Pharmaceutical Industries

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>